Welcia Holdings Co., Ltd. (3141) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Welcia Holdings Co., Ltd. (3141:JPX), powered by AI.

Current Price
¥3,160
P/E Ratio
43.8
Market Cap
654.4B
Sector
Healthcare
What is the Welcia Holdings Co., Ltd. stock price forecast?

Welcia Holdings Co., Ltd. is currently trading at ¥3,160. View real-time AI analysis on Alpha Lenz.

What is Welcia Holdings Co., Ltd. insider trading activity?

View the latest insider trading data for Welcia Holdings Co., Ltd. on Alpha Lenz.

What is Welcia Holdings Co., Ltd.'s P/E ratio?

Welcia Holdings Co., Ltd.'s P/E ratio is 43.8.

Welcia Holdings Co., Ltd.

JPX · 3141
¥3,160-93(-2.86%)Market closedJPX regular session 09:00–15:00 JST
Ask about Welcia Holdings Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Welcia Holdings Co., Ltd. trades at a P/E of 43.8 (premium valuation) with modest ROE of 6.2%.

Ask for details

Company Overview

Welcia Holdings Co., Ltd. is a prominent entity in Japan's retail sector, primarily focused on operating a chain of drugstores. The company's primary function is to provide a comprehensive range of health, wellness, and beauty products, catering to diverse consumer needs. Welcia is well-regarded for offering pharmaceuticals, over-the-counter medications, cosmetics, groceries, and daily essentials. One of its notable features is the integration of prescription services, enabling customers to fulfill their healthcare needs under one roof. The company serves various consumer segments, including individuals seeking medical supplies and personal care products. Welcia Holdings plays a crucial role in the retail industry by continuously expanding its footprint through strategic openings and acquisitions, thus enhancing its accessibility and market reach. Additionally, it emphasizes customer service excellence and convenience, forming a vital part of Japan’s robust drugstore sector. Headquartered in Tokyo, Welcia Holdings is instrumental in shaping retail pharmacy trends across the region, significantly impacting how consumers interact with health and beauty markets.

CEOMr. Hideaki Kirisawa
SectorHealthcare
IndustryPharmaceutical Retailers
Employees16,611

Company Statistics

FY 2025

Profile

¥654,399,555,720Market Cap
¥1,285,005,000,000Revenue
0.00Shares Out
16,611Employees

Margins

30.38%Gross
5.28%EBITDA
2.83%Operating
2.04%Pre-Tax
1.12%Net

Valuation

43.75P/E
2.63P/B
0.51EV/Sales
10.41EV/EBITDA
18.51P/FCF

Growth (CAGR)

7.79%Rev 3Yr
8.16%Rev 5Yr
-5.41%Op Inc 3Yr
-0.75%Op Inc 5Yr
-18.47%Net Inc 3Yr
-8.75%Net Inc 5Yr

Returns

2.53%ROA
6.15%ROE
4.78%ROIC

Financial Health

¥35,011,000,000Cash & Cash Equivalents
¥290,490,000,000Net Debt
127.91%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Welcia Holdings Co., Ltd. (ticker: 3141) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 16,611 employees. Market cap is $654.4B.

The current price is 3,160 with a P/E ratio of 43.75x and P/B of 2.63x.

ROE is 6.15% and operating margin is 2.83%. Annual revenue is $1.3T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Welcia Holdings Co., Ltd. (3141) Stock Forecast 2026 ¥3,160 — Price, Financials & Analyst Targets | Alpha Lenz